Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 6/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CTSD | P07339 | 1/20 | 0.38 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | CPB1 | P15086 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13853364 | 1.00 | CCR5 (0.53) | CCR5KCNH2OPRM1MEN1KMT2A | |
| SCHEMBL4196959 | 0.81 | CCR5 (0.55) | CCR5KCNH2OPRM1 | |
| SCHEMBL13853363 | 0.81 | CCR5 (0.55) | CCR5KCNH2OPRM1 | |
| SCHEMBL13853362 | 0.80 | MEN1 (0.52) | CCR5KCNH2OPRM1MEN1KMT2A | |
| SCHEMBL4193608 | 0.80 | MEN1 (0.52) | CCR5KCNH2OPRM1MEN1KMT2A | |
| SCHEMBL4197879 | 0.80 | OPRM1 (0.53) | CCR5OPRM1MEN1KMT2A | |
| SCHEMBL13853360 | 0.80 | OPRM1 (0.53) | CCR5OPRM1MEN1KMT2A | |
| SCHEMBL4198203 | 0.78 | OPRM1 (0.62) | CCR5KCNH2OPRM1MEN1KMT2A | |
| SCHEMBL4199727 | 0.77 | CCR5 (0.62) | CCR5KCNH2OPRM1 | |
| SCHEMBL13853329 | 0.77 | CCR5 (0.62) | CCR5KCNH2OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090124635-A1 | CHEMICAL COMPOUNDS | PFIZER INC. (GB) | 2009-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124635-A1 | CHEMICAL COMPOUNDS | CCR5, CXCR3, CCR2 | CCR5 1/4885KCNH2 2799/4885OPRM1 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.